Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 1, 2010, Pages

  Ratliff, B B ^a   Ghaly, T ^a   Brudnicki, P ^a   Yasuda, K ^a   Rajdev, M ^a   Bank, M ^a   Mares, J ^a   Hatzopoulos, A K ^b   Goligorsky, M S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adriamycin nephropathy; Ischemic injury; Neovascularization

Indexed keywords

DOXORUBICIN; HYALURONIC ACID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ENDOTHELIUM STEM CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATION; SPLEEN INJURY; STEM CELL; STEM CELL MOBILIZATION; STEM CELL NICHE;

EID: 77953859056     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00102.2010     Document Type: Article

References (42)

1. Abraham S, Eroshenko N, Rao R. Role of bioinspired polymers in determination of pluripotent stem cell fate. Regen Med 4: 561-578, 2009.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997. (Pubitemid 27087709)
3. Bladergroen B, Siebum B, Siebers-Vermeulen K, Van Kuppevelt T, Poot A, Feijen J, Figdor C, Torensma R. In vivo recruitment of hematopoietic cells using stromal cell-derived factor-1 alpha-loaded heparinized three-dimensional collagen scaffolds. Tissue Eng Part A 15: 1591-1599, 2009.
4. Burke J, Laucius J, Brodovsky H, Soriano R. Doxorubicin hydrochloride-associated renal failure. Arch Intern Med 137: 385-388, 1977.
5. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 289: F679-F684, 2005.
6. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24: 1246-1252, 2004.
7. Couture L, Nash J, Turgeon J. The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacol Rev 58: 244-258, 2006.
8. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45: 1449-1457, 2005.
9. Franke K, Pompe T, Bornhauser M, Werner C. Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells. Biomaterials 28: 836-843, 2007. (Pubitemid 44667018)
10. Gennaro G, Menard C, Michaud SE, Deblois D, Rivard A. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 110: 3367-3371, 2004.
11. Gerecht S, Burdick J, Ferreira L, Townsend A, Langer R, Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104: 11298-11303, 2007. (Pubitemid 47175135)
12. Ghosh K, Pan Z, Guan E, Ge S, Liu Y, Nakamura T, Ren X, Rafailovich M, Clark R. Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. Biomaterials 28: 671-679, 2007. (Pubitemid 44647459)
13. Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 24: 22-31, 2010.
14. Grayson W, Zhao F, Izadpanah R, Bunnell B, Ma T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207: 331-339, 2006.
15. Guest I, Uetrecht J. Drugs toxic to the bone marrow that target the stromal cells. Immunopharmacology 46: 103-112, 2000. (Pubitemid 30019252)
16. Hanson P, Mathews V, Marrus SH, Graubert TA. Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp Hematol 31: 159-167, 2003.
17. Hatzopoulos A, Folkman J, Vasile E, Eiselen G, Rosenberg R. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125: 1457-1468, 1998.
18. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
19. Holmen C, Elsheikh E, Stenvinkel P, Qureshi AR, Pettersson E, Jalkanen S, Sumitran-Holgersson S. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 16: 3110-3120, 2005.
20. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 23: 1831-1837, 2005.
21. Krankel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K, Schuler G, Hambrecht R. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25: 698-703, 2005.
22. Leach K. Multifunctional cell-instructive materials for tissue regeneration. Regen Med 1: 447-455, 2006.
23. Li Y, Chung E, Rodriguez R, Firpo M, Healy K. Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A79: 1-5, 2006.
24. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199, 2004.
25. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105: 1541-1544, 2002.
26. Moore K, Lemischka I. Stem cells and their niches. Science 311: 1880-1885, 2006.
27. Morrison S, Spradling A. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132: 598-611, 2008.
28. Ouyang A, Ng R, Yang S. Long-term culturing of undifferentiated embryonic stem cells in conditioned media and 3-dimensional fibrous matrices without extracellular matrix coating. Stem Cell 25: 447-454, 2007.
29. Patschan D, Krupincza K, Patschan S, Hamby C, Zhang Z, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after renal ischemia and ischemic preconditioning. Am J Physiol Renal Physiol 291: F176-F185, 2006.
30. Povsic T, Goldschmidt-Clermont P. Endothelial progenitor cells: markers of vascular reparative capacity. Ther Adv Cardiovasc Dis 2: 199-213, 2008.
31. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108: 457-463, 2003.
32. Rota M, LeCapitaine N, Hosoda T, Boni A, De Angelis A, Padin-Iruegas ME, Esposito G, Vitale S, Urbanek K, Casarsa C, Giorgio M, Luscher TF, Pelicci PG, Anversa P, Leri A, Kajstura J. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99: 42-52, 2006.
33. Schofield R. The relationship between the spleen colony-forming cell and the hematopoietic stem cell. Blood Cells 4: 7-25, 1978.
34. Sugawara J, Mitsui-Saito M, Hayashi C, Hoshiai T, Senoo M, Chisaka H, Yaegashi N, Okamura K. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 90: 5329-5332, 2005.
35. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
36. Toole B. Hyaluronan in morphogenesis. J Intern Med 242: 35-40, 1997.
37. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
38. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005. (Pubitemid 41262334)
39. Xie T, Li L. Stem cells and their niche: an inseparable relationship. Development 134: 2001-2006, 2007.
40. Yasuda K, Park HC, Ratliff B, Addabbo F, Hatzopoulos AK, Chander P, Goligorsky MS. Adriamycin nephropathy-a failure of endothelial progenitor cell-induced repair. Am J Pathol 176: 1685-1695, 2010.
41. Young P, Vaughan D, Hatzopoulos A. Biological properties of endothelial progenitor cells and their potential for cell therapy. Progr Cardiovasc Dis 49: 421-429, 2007.
42. Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90: 284-288, 2002.